Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Panacea Life Sciences's enterprise value was $1.16M on Oct 19, 2026, against $1.16M a year earlier. Over the last 5 years it ranged from -$1.22M to $7.06M, with a median of $1.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.16M | +45.0% |
| 2025 | Dec 31, 2025 | $798.42K | +134.4% |
| 2024 | Dec 31, 2024 | $340.64K | -86.7% |
| 2023 | Dec 29, 2023 | $2.57M | – |
| 2022 | Dec 30, 2022 | -$100.27K | – |
See a number that looks wrong?